Theme: Discovering, Innovating and Engineering Biological Science

Bioscience

Bioscience

Bioscience International Conferences invites all the participants from all over the world to attend Annual Conference on Bioscience 2016  during September 12-13, 2016 in Berlin, Germany which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Bioscience is defined as technologies that relate to therapeutic or diagnostic products or services, including medical devices and digital health technologies that improve human health.  Also included in the state definition are technologies that rely on research to improve agricultural output. As name “Bioscience” reflects belief that the study of biological systems is best approached by incorporating many perspectives. We bring together a diversity of disciplines that complement one another to unravel the complexity of biology. We incorporate the physical sciences, engineering, mathematics, computational and bioinformatics, and the social sciences, as appropriate, to problems we are addressing. We work with animals, plants and microorganisms and our research spans the levels of the biological hierarchy from molecules to ecosystems.

Bioscience International organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

This unique international conference provides a platform for researchers and decision makers in Bioscience to present their latest findings and learn about all the important developments in bioscience. Many scientists and world's renowned experts will participate in the conference. Throughout the course of the two day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate bioscience communities.

Target Audience:

The conference will attract a large group of scientists and researchers from round the globe. Delegates will have a valuable, informative and positive experience.

  • Biotechnologists
  • Pharmaceutical Experts
  • CEOs, CROs, directors and research associates from the bioscience  industries
  • Young Scientists
  • Academic Students
  • Bioscience Faculty
  • Bioscience Counselors
  • Business Entrepreneurs

Bioscience: It is defined as technologies that relate to therapeutic or diagnostic products or services, including medical devices and digital health technologies that improve human health.  Also included in the state definition are technologies that rely on research to improve agricultural output. As name “Bioscience” reflects belief that the study of biological systems is best approached by incorporating many perspectives. We bring together a diversity of disciplines that complement one another to unravel the complexity of biology. We incorporate the physical sciences, engineering, mathematics, computational and bioinformatics, and the social sciences, as appropriate, to problems we are addressing. We work with animals, plants and microorganisms and our research spans the levels of the biological hierarchy from molecules to ecosystems.

Related conferences: 10th Asia Pacific Biotech Congress July 25-27, 2016, Bangkok, Thailand; 2nd Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; 12th Biotechnology Congress, Nov 14-15, 2016, San Francisco, USA; Global Biotechnology Congress 2016, May 11th - 14th 2016, Boston, MA, USA; Biomarker Summit 2016, March 21-23, 2016 San Diego, CA, USA; 14th Vaccines Research & Development, July 7-8, 2016 Boston, USA; Pharmaceutical & Biotech Patent Litigation Forum, Mar 14 - 15, 2016, Amsterdam, Netherlands;

Molecular Biology:- Molecular Biology covers a wide scope of problems related to molecular and cell biology including structural and functional genomics, transcriptomics, proteomics, bioinformatics, biomedicine, molecular enzymology, molecular virology and molecular immunology, theoretical bases of biotechnology, physics and physical chemistry of proteins and nucleic acids. Unlike the majority of journals dealing with these subjects, Molecular Biology exercises a multidisciplinary approach and presents the complete pattern of relevant basic research mostly in Eastern Europe. Molecular Biology publishes general interest reviews, mini-reviews, experimental and theoretical works and computational analyses in molecular and cell biology.The molecular components make up biochemical pathways that provide the cells with energy, facilitate processing “messages” from outside the cell itself, generate new proteins, and replicate the cellular DNA genome. For example, molecular biologists study how proteins interact with RNA during “translation” (the biosynthesis of new proteins), the molecular mechanism behind DNA replication, and how genes are turned on and off, a process called “transcription.”

Related conferences:International Conference on Cervical Cancer, 22-23 September, 2016 (Vienna, Austria); 6th World Congress on Cancer Therapy, 01-03 December, 2016 (Baltimore, USA); 13th Global Summit on Cancer Therapy 17-19 October, 2016 (Dubai, UAE); International Conference on Pancreatic and Colorectal Cancer, 29-30 March, 2016 (Atlanta, USA); Global Summit on Melanoma And Carcinoma, 14-15 July, 2016 (Brisbane, Australia); Advances in Ovarian Cancer Research: Advance in Breast Cancer Research ( Washington, DC); Advances in Pediatric Cancer Research (Florida);  New Horizons in Cancer Research Conference (Sanghai, China

Microbiology:- Microbiology is the study of microscopic organisms, such as bacteria, viruses, archaea, fungi and protozoa. This discipline includes fundamental research on the biochemistry, physiology, cell biology, ecology, evolution and clinical aspects of microorganisms, including the host response to these agents. Microorganisms are beneficial for microbial biodegradation or bioremediation of domestic, agricultural and industrial wastes and subsurface pollution in soils, sediments and marine environments. The ability of each microorganism to degrade toxic waste depends on the nature of each contaminant.Symbiotic microbial communities are known to confer various benefits to their human and animal hosts health including aiding digestion, production of beneficial vitamins and amino acids, and suppression of pathogenic microbes. Some benefit may be conferred by consuming fermented foods, probiotics or prebiotics . The ways the microbiome influences human and animal health, as well as methods to influence the microbiome are active areas of research.Research has suggested that microorganisms could be useful in the treatment of cancer. Various strains of non-pathogenic clostridia can infiltrate and replicate within solid tumors. Clostridial vectors can be safely administered and their potential to deliver therapeutic proteins has been demonstrated in a variety of preclinical models.

Related conferences: 8th World Congress on Stem Cell Research March 20-22, 2017 Orlando, USA; 5th International Conference and Exhibition on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; International Conference on Molecular BiologyOctober 13-15, 2016 Dubai, UAE; 2nd International Conference on Tissue preservation and Biobanking  September12-13, 2016 Philadelphia USA; Conference on Cardiac Development April 3 – 7, 2016 Snowbird, Utah, USA; The Stem Cell Development May 22-26, 2016 Hillerød, Denmark; Hematopoietic Stem Cells: From the Embryo to the Aging Organism, June 3-5, 2016 Heidelberg, Germany; ISSCR Pluripotency: From basic science to therapeutic applications March 22-24, 2016 Kyoto, Japan

Molecular Biotechnology:- In its broadest sense, molecular biotechnology is the use of laboratory techniques to study and modify nucleic acids and proteins for applications in areas such as human and animal health, agriculture, and the environment.  Molecular biotechnology results from the convergence of many areas of research, such as molecular biology, microbiology, biochemistry, immunology, genetics, and cell biology.  It is an exciting field fueled by the ability to transfer genetic information between organisms with the goal of understanding important biological processes or creating a useful product.  The completion of the human genome project has opened a myriad of opportunities to create new medicines and treatments, as well as approaches to improve existing medicines.   Molecular biotechnology is a rapidly changing and dynamic field.  As the pace of advances accelerates, its influence will increase.  The importance and impact of molecular biotechnology is being felt across the nation.

Related conferences: Conference on Integrative Biology, July 18-20, 2016 (Berlin, Germany); International Conference on Clinical And Molecular Genetics, 28-30 November 2016 (Chicago, USA); 6th International Conference on Genomics and Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress on Human Genetics, 31 October–02 November 2016 (Barcelona, Spain);  Mitochondrial Medicine 2016, June 15-18, 2016 (Seattle,USA); The 2016 Gordon Research Conference on Mitochondria and Chloroplasts, June 19-24, 2016 (Vermont, USA); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada);

Food Science:- Food science draws from many disciplines such as biology, chemical engineering, and biochemistry in an attempt to better understand food processes and ultimately improve food products for the general public. As the stewards of the field, food scientists study the physical, microbiological, and chemical makeup of food. By applying their findings, they are responsible for developing the safe, nutritious foods and innovative packaging that line supermarket shelves everywhere.Academic Performance (85% of Admission Score): Admission to the Food Science major is based on a minimum academic standing of 70%, calculated based on the best 21 credits per year of post-secondary courses required in this program. The student must have completed ENGL 112 or equivalent. Elective courses and LFS 100, LFS 250, LFS 350, or LFS 450 are not included in this calculation.

Related conferences: Conference and Exhibition on Metabolomics, May 16-18, 2016 Osaka, International Conference on Genetic Counseling and Genomic Medicine August 11-12, 2016 Birmingham; Japan; 5th Conference on Tissue Science and Regenerative Medicine  September 12-14, 2016 Berlin, Germany; Conference on Restorative Medicine October 24-26, 2016 Chicago, USA;  Conference on Clinical and Molecular Genetics, November 28-30, 2016 Chicago, USA; Golden Helix Symposium, January 14-16, 2016, Mansoura, Egypt; Conference on  Personalized Medicine, July 10-15, 2016, Hong Kong, China; 18th International Conference on Pharmaceutical Engineering , March 30 - 31, 2016, Istanbul, Turkey.

Veterinary Bioscience:-Animals play an important role in society from ecological, social and economic perspectives and it is increasingly recognised that animal and human health are closely linked. Companion animals are an important feature of our culture and socio-psychological wellbeing, as are animals used for recreational purposes. The demand for production of animals for food continues to grow as we attempt to feed a growing world population and to raise global living standards. This demand is coupled with the increasing recognition of the important role of wildlife in the broad ecosystem and of the need to enhance sustainability.Animal and Veterinary Bioscience combines fundamental biological disciplines such as chemistry, biochemistry, biostatistics and microbiology with courses that examine animals from the molecular scale through to whole animal populations.You will acquire a sound biological training to form the basis for on-going research training, application to industry or related sectors, or professional program progression such as veterinary science.

Related conferences:

International Conference on Genetic Counselling and Genomic  Medicine, 11-12 August, 2016 (Birmingham, UK); World Congress on Human Genetics, 31October – 02November 2016 (Valencia, Spain);  Cell and Gene Therapy Congress, 19-21 May 2016 ( San Antonio, USA); The 44nd Biennial American Cytogenetics Conference,16-18 May, 2016 (Oregon, USA); The European Human Genetics Conference 2016, 21-24 May, 2016 (Barcelona, Spain); 4th International workshop on Cancer Genetic and Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada); Game of Epigenetics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia); Game of Epigenomics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia); The 44ndBiennial American Cytogenetic Conference,16-18 May, 2016 (Oregon, USA); The European Human Genetics Conference 2016, 21-24 May, 2016 (Barcelona, Spain); 4th International workshop on Cancer Genetics and Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada).

Forensic Science:- Forensic science is the application of science to criminal and civil laws. Forensic scientists collect, preserve, and analyse scientific evidenceduring the course of an investigation. While some forensic scientists travel to the scene to collect the evidence themselves, others occupy a purely laboratory role, performing analysis on objects brought to them by other individuals.In addition to their laboratory role, forensic scientists testify as expert witnesses in both criminal and civil cases and can work for either the prosecution or the defense. While any field could technically be forensic, certain sections have developed over time to encompass the majority of forensically related cases.

Related conferences:  4th International workshop on Cancer Genetic and Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada); Game of Epigenetics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia); Game of Epigenomics Conference, 24 - 26 April 2016 (Dubrovnik, Croatia); The 44nd Biennial American Cytogenetic Conference,16-18 May, 2016 (Oregon, USA); The European Human Genetics Conference 2016, 21-24 May, 2016 (Barcelona, Spain); 4th International workshop on Cancer Genetics and Cytogenetic Diagnostics, 6-8 April, 2016, (Nijmegen, Netherlands); Chromatin and Epigenetics, 20-24 Mar 2016 (Whistler, Canada)

Bioprocess and Biological Engineering:-Bioprocess engineering is the alteration or application of renewable materials to generate value-added products. It encompasses discovery, research, development and the manufacturing and commercialization of products. Products developed include: fuels, food, feed, pharmaceuticals, nutraceuticals and a multitude of value-added biomaterials found in and used by all industries.

Related conferences: Conference and Exhibition on Metabolomics, May 16-18, 2016 Osaka, International Conference on Genetic Counseling and Genomic Medicine August 11-12, 2016 Birmingham; Japan; 5th Conference on Tissue Science and Regenerative Medicine  September 12-14, 2016 Berlin, Germany; Conference on Restorative Medicine October 24-26, 2016 Chicago, USA;  Conference on Clinical and Molecular Genetics, November 28-30, 2016 Chicago, USA; Golden Helix Symposium, January 14-16, 2016, Mansoura, Egypt; 18th International Conference on Pharmaceutical Engineering , March 30 - 31, 2016, Istanbul, Turkey.

Agriculture Bioscience:- ;- Agriculture is the systematic raising of useful plants and livestock under the management of man. Agricultural Activity means the cultivation of the soil, planting of crops, growing of fruit trees, including the harvesting of such farm products, and other farm activities and practices performed by a farmer in conjunction with such farming operations done by persons whether natural or juridical. The practice of agriculture is based on systematized body of knowledge (science) and requires skill (art).

Related conferences:Conference and Exhibition on Metabolomics, May 16-18, 2016 Osaka, International Conference on Genetic Counseling and Genomic Medicine August 11-12, 2016 Birmingham; Japan; 5th Conference on Tissue Science and Regenerative Medicine  September 12-14, 2016 Berlin, Germany; Conference on Restorative Medicine October 24-26, 2016 Chicago, USA;  Conference on Clinical and Molecular Genetics, November 28-30, 2016 Chicago, USA; Golden Helix Symposium, January 14-16, 2016, Mansoura, Egypt; 18th International Conference on Pharmaceutical Engineering , March 30 - 31, 2016, Istanbul, Turkey.

Biopharmaceutics and Biochemistry:- Biopharmaceutics is the study which shows how the drug absorption rate is affected by various factors like physical and chemical properties of the drug, the dose form of the drug and the route through which the drug is administered. Drugs are substances intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. Drugs are given in a variety of dosage forms or drug products such as solids (tablets, capsules), semisolids (ointments, creams), liquids, suspensions, emulsions, etc, for systemic or local therapeutic activity. Drug products can be considered to be drug delivery systems that release and deliver drug to the site of action such that they produce the desired therapeutic effect and are also designed specifically to meet the patient's needs including palatability, convenience, and safety.Medical biotechnology is the use of living cells and cell materials to research and produce pharmaceutical and diagnostic products that help treat and prevent human diseases. Most medical biotechnologists work in academic or industrial settings. In academic laboratories, these professionals conduct experiments as part of medical research studies.

Related conferences: 10th Asia Pacific Biotech Congress July 25-27, 2016, Bangkok, Thailand; 2nd Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; 12th Biotechnology Congress, Nov 14-15, 2016, San Francisco, USA; Global Biotechnology Congress 2016, May 11th - 14th 2016, Boston, MA, USA; Biomarker Summit 2016, March 21-23, 2016 San Diego, CA, USA; 14th Vaccines Research & Development, July 7-8, 2016 Boston, USA; Pharmaceutical & Biotech Patent Litigation Forum, Mar 14 - 15, 2016, Amsterdam, Netherlands;

Nano-Biotechnology:- Nanotechnology is the engineering of functional systems at the molecular scale. This covers both current work and concepts that are more advanced.In its original sense, 'nanotechnology' refers to the projected ability to construct items from the bottom up, using techniques and tools being developed today to make complete, high performance products.

Related conferences: 10th Asia Pacific Biotech Congress July 25-27, 2016, Bangkok, Thailand; 2nd Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; 12th Biotechnology Congress, Nov 14-15, 2016, San Francisco, USA; Global Biotechnology Congress 2016, May 11th - 14th 2016, Boston, MA, USA; Biomarker Summit 2016, March 21-23, 2016 San Diego, CA, USA; 14th Vaccines Research & Development, July 7-8, 2016 Boston, USA; Pharmaceutical & Biotech Patent Litigation Forum, Mar 14 - 15, 2016, Amsterdam, Netherlands;

Biodiversity,Ecology and Evolution:- Bio means life diversity means variety biodiversity  refers to the variety of life.biodiversity is that part of nature which includes the differences in genes among the individuals of a species,the variety and richness of all the plant animal species at different scales in space locally in a region,in the country and the world and various types of ecosystems,both terrestrial and aquatic,with in a defined area.

Related conferences: 10th Asia Pacific Biotech Congress July 25-27, 2016, Bangkok, Thailand; 2nd Industrial Biotechnology Congress, July 28-29, 2016, Berlin, Germany; 12th Biotechnology Congress, Nov 14-15, 2016, San Francisco, USA; Global Biotechnology Congress 2016, May 11th - 14th 2016, Boston, MA, USA; Biomarker Summit 2016, March 21-23, 2016 San Diego, CA, USA; 14th Vaccines Research & Development, July 7-8, 2016 Boston, USA; Pharmaceutical & Biotech Patent Litigation Forum, Mar 14 - 15, 2016, Amsterdam, Netherlands;

Biomedical Science:- study human diseases in order to improve human health and  Investigations carried out by biomedical scientists on body fluids and samples of tissue to identify the nature of the medical condition of disease and monitor  the treatment of patients. The branches of medical science that deal with nonsurgical techniques, studies the causes and nature and effects of diseases and  dealing with the medical use of X-rays or other penetrating radiation and nervous system.

Related conferences: Conference and Exhibition on Metabolomics, May 16-18, 2016 Osaka, International Conference on Genetic Counseling and Genomic Medicine August 11-12, 2016 Birmingham; Japan; 5th Conference on Tissue Science and Regenerative Medicine  September 12-14, 2016 Berlin, Germany; Conference on Restorative Medicine October 24-26, 2016 Chicago, USA;  Conference on Clinical and Molecular Genetics, November 28-30, 2016 Chicago, USA; Golden Helix Symposium, January 14-16, 2016, Mansoura, Egypt; 18th International Conference on Pharmaceutical Engineering , March 30 - 31, 2016, Istanbul, Turkey.

Biophysics:- Biophysics is an interdisciplinary science that applies the approaches and methods of physics to study biological systems. Biophysics covers all scales of biological organization, from molecular to organismic and populations. Biophysical research shares significant overlap with biochemistry, nanotechnology, bioengineering, computational biology and systems biology.Biophysicists study life at every level, from atoms and molecules to cells, organisms, and environments. Bio-implants have emerged as a promising solution for the variety of conditions such as cardiovascular, dental, orthopedic, ophthalmology, neurological disorders and others. Global market is forecast to reach $115.8 billion by 2020, registering a CAGR of 10.3% from 2014 to 2020.

Related conferences:Conference and Exhibition on Metabolomics, May 16-18, 2016 Osaka, International Conference on Genetic Counseling and Genomic Medicine August 11-12, 2016 Birmingham; Japan; 5th Conference on Tissue Science and Regenerative Medicine  September 12-14, 2016 Berlin, Germany; Conference on Restorative Medicine October 24-26, 2016 Chicago, USA;  Conference on Clinical and Molecular Genetics, November 28-30, 2016 Chicago, USA; Golden Helix Symposium, January 14-16, 2016, Mansoura, Egypt; 18th International Conference on Pharmaceutical Engineering , March 30 - 31, 2016, Istanbul, Turkey.

Biochemical Engineering:- Biochemical engineers translate exciting discoveries in life sciences into practical materials and processes contributing to human health and well-being.biochemical engineering is mainly deals with the design and construction of unit processes that involve biological organisms or molecules, such as bioreactors.Its applications are in the petrochemical industry, food, pharmaceutical, biotechnology, and water treatment industries.

Related conferences: Conference and Exhibition on Metabolomics, May 16-18, 2016 Osaka, International Conference on Genetic Counseling and Genomic Medicine August 11-12, 2016 Birmingham; Japan; 5th Conference on Tissue Science and Regenerative Medicine  September 12-14, 2016 Berlin, Germany; Conference on Restorative Medicine October 24-26, 2016 Chicago, USA;  Conference on Clinical and Molecular Genetics, November 28-30, 2016 Chicago, USA; Golden Helix Symposium, January 14-16, 2016, Mansoura, Egypt; 18th International Conference on Pharmaceutical Engineering , March 30 - 31, 2016, Istanbul, Turkey.

Bioinformatics and Computational Biology:- Bioinformatics is the application of computer technology to the management of biological information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied to gene-based drug discovery and development.Examples of bioinformatics studies include analysis and integration of -omics data, prediction of protein function from sequence and structural information, and cheminformatics comparisons of protein ligands to identify off-target effects of drugs.

Related conferences:International Conference on Next Generation Sequencing July 21-22, 2016 Berlin, Germany; 5th InternationalConference on Computational Systems Biology August 22-23, 2016 Philadelphia, USA; 7th InternationalConference on Bioinformatics October 27-28, 2016 Chicago, USA; International Conference on Synthetic Biology September 28-30, 2015 Houston, USA; 4th International Conference on Integrative Biology July 18-20, 2016 Berlin, Germany; 1st International Conference on Pharmaceutical Bioinformatics Jan 24–26 2016, Pattaya, Thailand; EMBL Conference: The Epitranscriptome, Apr 20–22 2016, Heidelberg, Germany; 2016 Whole-Cell Modeling Summer School, Apr 3–8 2016, Barcelona, Spain; 3rd International Molecular Pathological Epidemiology, May 12–13 2016, Boston, USA; 5th Drug Formulation, Jan 25–27 2016, Philadelphia, USA

Biometrics and Biostatistics:-Biometric and biostatistics are regulation of biological sciences  concerned with the , principles  and practices to the observation  ,application of mathematical-statistical theory, measurement, and analysis of biological data and phenomena. Biostatistics deals with the approach of statistics to a broad range of topics in biology.

Related conferences:International Conference on Next Generation Sequencing July 21-22, 2016 Berlin, Germany; 5th InternationalConference on Computational Systems Biology August 22-23, 2016 Philadelphia, USA; 7th InternationalConference on Bioinformatics October 27-28, 2016 Chicago, USA; International Conference on Synthetic Biology September 28-30, 2015 Houston, USA; 4th International Conference on Integrative Biology July 18-20, 2016 Berlin, Germany; 1st International Conference on Pharmaceutical Bioinformatics Jan 24–26 2016, Pattaya, Thailand; EMBL Conference: The Epitranscriptome, Apr 20–22 2016, Heidelberg, Germany; 2016 Whole-Cell Modeling Summer School, Apr 3–8 2016, Barcelona, Spain; 3rd International Molecular Pathological Epidemiology, May 12–13 2016, Boston, USA; 5th Drug Formulation, Jan 25–27 2016, Philadelphia, USA

Source BioScience is an international laboratory services and products business with nine state of the art facilities in five countries and with customers in over 90 countries worldwide. The Group offers a complementary portfolio of services and products that share common technologies, laboratory processes, infrastructure and expertise.

LifeSciences

LifeSciences delivered revenue of £7.2 million (2013: £7.6 million) and a divisional operating profit of £1.1 million (2013: £1.2 million) as the Group invested to extend its market coverage and expand its specialist product offering. Source BioScience’s ambition is to become Europe and the USA’s leading commercial provider of DNA sequencing and the Overnight Service™, which provides rapid access to sequencing data, is instrumental in achieving this. The Group’s market share in the UK continues to increase and DNA sequencing volumes during 2014 were over 30% greater thanthe prior year, driving both revenue and margin growth.

Healthcare

Healthcare revenue increased by 7% to £10.0 million (2013: £9.4 million) and divisional operating profit increased by 15% to £3.4 million (2013: £3.0 million).The diagnostic activities continued the impressive performance reported at the half year and the aggregate number of diagnostic tests conducted increased by over 70% compared with 2013.

Bioscience 2015 was published in 2003. Today, nearly six years later, one is bound to have mixed reactions about what has been achieved by the UK bioscience sector. More worrying are the immediate prospects for what should be one of our high achieving, knowledge based industries. Senior people from Bioscience companies, Government Departments, Trade Associations, universities and research bodies have been involved in the Review and Refresh of Bioscience 2015. This report reflects the broad consensus of their views, through not necessarily those of the Government or Government officials, nor individuals, companies or organisations involved in the process.

A vision for bioscience

Over the five years since Bioscience 2015 was published, UK bioscience companies have struggled to achieve the vision it laid out, while other European companies have caught up with the UK in terms of projects in the pipeline. For example, in 2002 46% of the EU products in clinical trial development were in the UK. By 2007 this had reduced to 24% and analysis of the numbers of UK companies listed since 2002 shows that the number of companies with a market capitalisation of less than £25m has increased (see Market Capitalisation graph Fig 5) while the number of companies with a market capitalisation of more than £25 million has decreased. Therefore, although there may be a similar number of companies there is significantly less investment in those companies, preventing

them from growing18 which is contrary to the hopes for the sector held in 2003. Therefore, there is a need for a more realistic vision given what is achievable in the time frame to 2015.

 

 

Increasing finance to bioscience SMEs: Government schemes

Government provides a number of schemes to support enterprises and is currently undertaking an exercise to simplify the support available. Businesses in all sectors will benefit from a simplified business support landscape, which will help them access the provision they need more easily. There are particular issues around the high risk of investing in bioscience, which have meant that the sector has not been able to fully benefit from some of the schemes.

In 2014, the European trend lines followed those in the US, albeit the trajectories for each of the key performance metrics did not reach the same heights. European biotech companies saw their revenue growth rebound strongly in 2014, as top-line sales expanded 15%, compared to the modest 3% uptick of 2013. In a sign of a healthier financial picture, 77% of European biotechs generated some revenue and 69% increased their top lines year over year. Those results are comparable to the revenue metrics posted by US biotech companies.

EU Clinical Trials Directive – Directive implemented in 2004 with the aim of patient protection, improved research reporting, harmonisation and increased competitiveness of European clinical research.

As in the US, European biotech companies’ aggregate net income increased by a healthy percentage, spiking 199% to US$3.3 billion. This percentage increase didn’t match the steep growth rate of 2013, when net income soared by 462%. It was also heavily influenced by the US$1.6 billion breakup fee Shire received from AbbVie when the proposed merger between the two companies was called off in October 2014.

 

Research and development undertaken by the bioscience sector is particularly expensive. R&D tax credits are a valuable source of Government support for the sector not least because they stimulate innovation. Bioscience companies are often loss making in their R&D phase, therefore a tax credit is much more favourable than a corporation tax cut which is of no benefit to such companies because there are no profits against which to levy the tax.

Adjusting for this one-time event, European biotech companies actually added US$533 million in aggregate net income in 2014, an annual increase of 52%. This increase was driven largely by strong performances by Medivir, Actelion and Amarin, which each increased their net income by at least US$90 million. Indeed, only 45% of European biotechs boosted their net income in 2014, compared to 50% in 2013. Among those with sizeable drops in net income were Meda and Jazz Pharmaceuticals, while Alkermes reported a net loss. Meda’s net income fell as a result of one-time restructuring charges related to its Rottapharm acquisition, while the bottom lines of both Jazz and Alkermes were affected by the aforementioned increases in their R&D budgets.

 

                                       

             

  The market capitalizations of European biotech companies increased strongly for the second straight year amid positive investor sentiment. Indeed, market caps of European companies actually increased seven percentage points more than those in the US in 2014. A catch-up phenomenon was at least partly responsible, given that European biotech market valuations didn’t increase as dramatically in 2013 as those of US biotechs, there was more room for a run-up in 2014. In all, 59% of European biotechs saw their market caps increase in 2014.

Biotechnology-2015

OMICS International feel proud to announce the report of 394th International conference with the name 6th World Congress on Biotechnology which was held in New Delhi on 05-07 October 2015. The conference was held under the auspices of Directors, Professors, Biotechnology scientists, researchers and industry professionals. A number of new initiatives were introduced as part of this year’s conference. The theme for this year’s conference was “Biotechnology: Meeting the Needs of a Changing World ”. Specifically, the Conference program addressed leading practice approaches to Biotechnology applications provided an opportunity to discuss and challenge some current practices and discuss emerging tools and techniques to drive continuous improvement in outcomes in Bio-Industry. Delegates included from USA, India, Chile , Korea, Brazil, Armenia, , Saudi Arabia and several other countries have experienced the beauty of New Delhi, which is one of most beautiful cities of India.

The conference initiated with keynote speeches, other scientific sessions, plenary speeches and Poster sessions. The Highlights of the conference are:  

  • Workshop on “NIH Research Resources in Biotechnology” by Mukesh Verma, National Institute of Health, USA.
  • Keynote talk by Mukesh Verma, National Institute of Health, USA
  • Keynote talk by B M Gandhi , Formerly Advisor to the Government of India     
  • Keynote talk by Mousumi Mutsuddi from Banaras Hindu University, India

We appreciate the effort and extend our sincere gratitude to Mousumi Mutsuddi from Banaras Hindu UniversityMahima Gulabani from University of Delhi, India, Nameet Kaur From Sharda University, India for taking and fulfilling the duty of moderator and support in making the conference a grand success.

We have succeeded in bringing together leading experts and biotechnologists from all over the world. With this success and the interest among the researchers, we are happy to launch 11th World Congress on Biotechnology at New Delhi, India. We welcome all the eminent personalities, industry professional, researchers, students and delegates to take part in this upcoming conference in the wonderful city of New Delhi.


Past Reports  Gallery  

Biotechnology-2014
OMICS International Conferences successfully hosted its premier 5th World Congress on Biotechnology during June25-27, 2014 Valencia Conference centre, Valencia Spain

This World congress was accomplished by the support of European Biotechnology Thematic Network Association (EBTNA), Valencia Bioregion (BIOVAL), Federation of Spanish Biotechnologist (FEBiotec) and Società Italo-Latinoamericana di Etnomedicina (SILAE). Biotechnology-2014 marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This 5th World Congress on Biotechnology was based on the theme the theme “Biotechnology: Meeting the Needs of a Changing World” which has covered the below scientific sessions:

  • Current Scenario of Biotechnology
  • Biotechnology in Agriculture
  • Biotechnology in Health Care
  • Food and Bioprocess Technology
  • Cancer and Genomics Research
  • Immunology and Stem Cell Therapy
  • Genetic Engineering and rDNA Technology
  • Biochemistry, Cell and Molecular biology
  • Microbiology and Microbial World
  • Animal Biotechnology and Cell Culture
  • Bioinformatics and Biosensor
  • Marine Biotechnology and Renewable Energy technology
  • Petroleum and Environmental Biotechnology

The conference was greeted by the welcome message of Prof. Cheorl-Ho Kim Sung Kyun Kwan University, Korea and moderated by Prof. Martin J. D’Souza, Mercer University, USA.  The support was extended by the below honourable guest Em. Prof. Marc Van Montagu, (World Food Laureate 2013) University of Gent, Belgium, Prof. Roberto Gaxiola,  Arizona State University, USA, Prof. Ara Kanekanian, Cardiff Metropolitan University, UK, Prof. Manuel P. Alonso, University of Valencia, Spain, Prof. Cheorl-H. Kim, Sung Kyun Kwan University, Dr. Srinubabu Gedela, OMICS Group Inc, USA and below keynote lectures:

  • GM crops: Achievements and controversy, Em. Prof. Marc Van Montagu, VIB Institute of Plant Biotechnology Outreach, University of Ghent, Belgium
  • Engineering crops with enhanced water and nutrient use efficiencies, Prof. Roberto Gaxiola, Arizona State University, USA
  • Functional ingredients from foods for their health properties, Prof. Ara Kanekanian, Cardiff Metropolitan University, UK
  • Basic genomic research to biomedical research to translational medicine to medical applications, Prof. Manuel P. Alonso, University of Valencia, Spain
  • Tumor cell sensitization to anti-tumor agent-induced apoptosis, Prof. Cheorl-H. Kim, Sung Kyun Kwan University, Korea
  • How secreted AGR2 helps tumor cells to establish its microenvironment , Prof. Dawei Li, Shanghai Jiao Tong University, China
  • Microbial cell surface displaying enzymes: Construction, characterization and biosensing applications, Prof. Aihua Liu, Chinese Academy of Sciences, China.

OMICS International acknowledge the support of below Chairs and Co-chairs foe whom we were able to run smoothly the scientific sessions includes: Alain Goossens, Ghent University, Belgium, Oscar Vicente, IBMCP, Polytechnic University of Valencia, Spain, Ara Kanekanian, Cardiff Metropolitan University, UK, Ana M. Hortigüela, Instituto de Medicina Genómica, Spain, Cheorl-H Kim, Sung Kyun Kwan University, Korea, Martin J. D’Souza, Mercer University, USA, Marina V. Frontasyeva, Joint Institute for Nuclear Research, Russian Federation, Zlatka Alexieva, Bulgarian Academy of Sciences, Bulgaria, Salvador Ventura, Universitat Autònoma de Barcelona, Spain, Giuseppe Manco, Institute of Protein Biochemistry, National Research Council (CNR), Italy, Aihua Liu, Qingdao Institute of Bioenergy & Bioprocess, CAS, China, Amparo Pascual-Ahuir Giner, Universidad Politecnica de Valencia, Spain.

The Biotechnology-2014 also being highlighted for the below International Symposiums under various tracks:

  • GM crops to feed the world in the XXI century and the risks posed by the irrational opposition of radical ecologists by Prof. Ramon Serrano, Polytechnic University of Valencia, Spain.
  • Biotechnology for wastewater treatment by Prof. Marina V. Frontasyeva, Joint Institute for Nuclear Research, Russian Federation
  • Enzyme Based Biosensors-Development & Applications by Prof. Aihua Liu, Qingdao Institute of Bioenergy & Bioprocess, CAS, China

This 5th World Congress on Biotechnology uplifted with more than 120 poster presentationsby researchers, students, professors, industry delegates around 25 countries across the globe.

OMICS Group International has taken the privilege of felicitating Biotechnology-2014 Organizing Committee Members, Editorial Board Members of the supported Journals and Keynote Speakers who supported for the success of this event and special privilege to Em. Prof. Marc Van Montagu for his contribution to Agrobiotechnology.

Last but not the least OMICS International Conferences wishes to acknowledge with its deep sincere gratitude to all the supporters from  the Editorial Board Members of our Open Access Journals, Keynote speakers, Honourable guests, Valuable speakers, Poster presenters, students, delegates and special thanks to the Media partners and Collaborators for their promotion to make this event a huge success.

With the enormous feedback from the participants and supporters of 5th World Congress on Biotechnology, OMICS Group Conferences is glad to announce its 6th World Congress on Biotechnology from October 05-07, New Delhi India.


Past Reports  Gallery  

Biotechnology-2013

 

“4th World Congress on Biotechnology” which was organized by OMICS international on September 23-25, 2013 at Raleigh-North Carolina, USA, provided a vibrant and challenging rostrum to all Biotechnologists, students, academicians and industries across the globe.

The three days lasted conference of merit, succeeded in magnetizing a good folk yearning for quality and novelty rich updates on modern Biotechnology. Day-1 started with inaugural ceremony, opening the doorway to magnificent and most awaited speeches. The opening speech was backed up by speeches derived by honorable guests & keynote forum and invited lectures by honorable moderator, chair & co-chair of each session. Biotechnology 2013 witnessed the essence of the theme “Unveiling the Current Frontiers in the Field of Biotechnologyall the three daysThe meet did unveil the current, novel and most intriguing frontiers in the field of biotechnology. The event marked the right podium promulgating various topics from the enlightening arenas of Microbial and Biochemical Technology, Bioremediation and Biodegradation, Petroleum and Environmental Biotechnology, Genetic Engineering and Molecular Biology, Clinical and Cellular Immunology, Medical Biotechnology and Biomedical Engineering, and many more.

The three day conference received immense response and every session was thought provoking and cerebrating. It brought together blend of experts across the globe under a common roof which helped boost discussions and which we hope shall pave a new future to the field of Biotechnology. The focus points of the symposium were the cogitating speeches delivered by Dr. AraKanekanianCardiff Metropolitan University, UK, titled “The role of bioactive peptides and probiotics in human health”and by Dr. Jimmy T. Efird, on “Targeted analytic methods for deep sequencing”. Other eminent speeches provided a great opportunity for the participants to share knowledge on their individual research areas, research problems and the advanced methods.

We are thankful for your invaluable contribution to Biotechnology-2013 congregation that came out with flying colors in response to the inestimable inputs of experts and adepts with their enormous, eminent and invaluable research works and presentations. Our special thanks to the moderator, session chair and co-chair of the conference. Also, our heartfelt gratitude to our editorial board members, organizing committee members and media partners for their enormous support.

Your rejoinder is our inspiration. We shall endeavor to maintain this continuum of success an evergreen one. With the forthcoming and eventual advancements in the arena of biotechnology, see you again in Biotechnology-2014!!!


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 12-13, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
bioscience@insightconferences.com
Sponsors / Exhibiting / Advertising.
bioscience@conferenceseries.net
General Queries.
bioscience@conferenceseries.com

View Proceedings of Previous Conferences

Biotechnology 2015
Biotechnology 2014
Biotechnology 2013
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.